Max leads the CyberTalent division of the SANS Institute, the most trusted and the largest provider of information security training and certification in the world. In this role, he directs business development and external stakeholder engagement to scale the various SANS CyberTalent programs and develop strategic partnerships. He also oversees the CyberTalent program operations and staff management. SANS CyberTalent helps organizations in both the public and private sectors address their cybersecurity human capital needs through initiatives such as VetSuccess, the Women's Immersion Academy, and the CyberTalent Assessments, among others. Max joined SANS Institute as its' CyberTalent Business Development manager in 2015.

Max has worked in the public affairs and stakeholder engagement arena of cybersecurity for the past five years, working with Government, corporate, and not-for-profit organizations, most recently as a Vice President at Cambridge Global Advisors, a homeland security strategic advisory services firm. He also previously served as the national recruitment director for the Cyber Aces Foundation, a nonprofit organization that trained and educated veterans, jobseekers, and students in cybersecurity via online training modules.

Max also has supported the U.S. Department of Homeland Security's (DHS) CyberSkills Management Support Initiative (CMSI), an initiative within NPPD focused on building partnerships with academic institutions and NGOs as well as growing the cybersecurity talent pipeline for DHS through programs like the Cyber Student Volunteer Initiative.

Max has a Bachelor's degree in Comparative Cultures and Politics from Michigan State University with a second degree in International Relations and a minor in Spanish. At Michigan State, he was a co-chair and fundraising director for the local Habitat for Humanity chapter. Additionally, he served as a Research Assistant to Distinguished Professor Richard Zinman of the James Madison College at MSU on international security and foreign relations policy.